208 related articles for article (PubMed ID: 20108491)
1. Hyperhomocysteinemia in renal diseases.
Ferechide D; Radulescu D
J Med Life; 2009; 2(1):53-9. PubMed ID: 20108491
[TBL] [Abstract][Full Text] [Related]
2. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
4. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients.
Righetti M; Ferrario GM; Milani S; Serbelloni P; La Rosa L; Uccellini M; Sessa A
Med Sci Monit; 2003 Apr; 9(4):PI19-24. PubMed ID: 12709680
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.
Sunder-Plassmann G; Winkelmayer WC; Födinger M
Expert Opin Investig Drugs; 2000 Nov; 9(11):2637-51. PubMed ID: 11060826
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia as a risk factor after renal transplantation.
Ducloux D; Motte G; Massy ZA
Ann Transplant; 2001; 6(4):40-2. PubMed ID: 12035457
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
Perna AF; Sepe I; Lanza D; Pollastro RM; De Santo NG; Ingrosso D
J Ren Nutr; 2012 Jan; 22(1):191-4. PubMed ID: 22200441
[TBL] [Abstract][Full Text] [Related]
9. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine metabolism in renal failure.
van Guldener C; Stam F; Stehouwer CD
Kidney Int Suppl; 2001 Feb; 78():S234-7. PubMed ID: 11169017
[TBL] [Abstract][Full Text] [Related]
11. [Homocysteine--new risk factor for progression of atherosclerosis and its complications].
Brzósko S; Hryszko T; Małyszko J; Myśliwiec M
Pol Merkur Lekarski; 2001 Jan; 10(55):56-9. PubMed ID: 11320555
[TBL] [Abstract][Full Text] [Related]
12. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine and cardiovascular disease in renal disease.
Austen SK; Coombes JS; Fassett RG
Nephrology (Carlton); 2003 Dec; 8(6):285-95. PubMed ID: 15012699
[TBL] [Abstract][Full Text] [Related]
14. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine in neurological disease: a marker or a cause?
Khanna S; Kapoor P; Pillai KK; Vohora D
CNS Neurol Disord Drug Targets; 2011 May; 10(3):361-9. PubMed ID: 20874694
[TBL] [Abstract][Full Text] [Related]
17. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia and advancement of atherosclerosis in patients with chronic renal failure on maintenance hemodialysis].
Sydor A; Drozdz M; Kraśniak A; Miłkowski A; Chmiel G; Małczak J; Zabawa-Hołyś S; Moskal K; Podwysocki A; Szmigielski M; Czarnecka D; Gozdecka H; Kowalczyk-Michałek M; Szczeklik A; Wiecek A; Sułowicz W
Przegl Lek; 2002; 59(12):962-7. PubMed ID: 12731367
[TBL] [Abstract][Full Text] [Related]
19. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
Tungkasereerak P; Ong-ajyooth L; Chaiyasoot W; Ong-ajyooth S; Leowattana W; Vasuvattakul S; Vareesangthip K; Shayakul C; Chanchairujira T; Sritippayawan S
J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
[TBL] [Abstract][Full Text] [Related]
20. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
Caramia G; Belardinelli R
Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
